Orchestra BioMed Holdings Inc’s recent filing unveils that its insider Hochman David P acquired Company’s shares for reported $18640.0 on Dec 23 ’24. In the deal valued at $4.66 per share,4,000 shares were bought. As a result of this transaction, Hochman David P now holds 579,498 shares worth roughly $1.66 million.
Then, Taylor Andrew Lawrence bought 1,000 shares, generating $4,830 in total proceeds. Upon buying the shares at $4.83, the Chief Financial Officer now owns 344,960 shares.
Before that, Hochman David P bought 5,000 shares. Orchestra BioMed Holdings Inc shares valued at $24,550 were divested by the insider at a price of $4.91 per share. As a result of the transaction, Hochman David P now holds 575,498 shares, worth roughly $1.65 million.
BTIG Research initiated its Orchestra BioMed Holdings Inc [OBIO] rating to a Buy in a research note published on March 20, 2025; the price target was $12. A number of analysts have revised their coverage, including Barclays’s analysts, who began to cover the stock in early January with a ‘”an Overweight”‘ rating. H.C. Wainwright began covering OBIO with “Buy” recommendation on August 22, 2024. B. Riley Securities started covering the stock on July 25, 2024. It rated OBIO as “a Buy”.
Price Performance Review of OBIO
On Tuesday, Orchestra BioMed Holdings Inc [NASDAQ:OBIO] saw its stock jump 0.70% to $2.86. Over the last five days, the stock has gained 2.14%. Orchestra BioMed Holdings Inc shares have fallen nearly -28.50% since the year began. Nevertheless, the stocks have fallen -39.28% over the past one year. While a 52-week high of $8.87 was reached on 01/02/25, a 52-week low of $2.49 was recorded on 04/07/25. SMA at 50 days reached $4.11, while 200 days put it at $5.41.
Levels Of Support And Resistance For OBIO Stock
The 24-hour chart illustrates a support level at 2.51, which if violated will result in even more drops to 2.17. On the upside, there is a resistance level at 3.22. A further resistance level may holdings at 3.59. The Relative Strength Index (RSI) on the 14-day chart is 37.25, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.05, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 66.67%. Stochastics %K at 24.15% indicates the stock is a holding.
How much short interest is there in Orchestra BioMed Holdings Inc?
A steep rise in short interest was recorded in Orchestra BioMed Holdings Inc stocks on 2025-03-31, growing by 47464.0 shares to a total of 0.57 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 0.52 million shares. There was a rise of 8.29%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on January 19, 2024 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $14 price target.
